RxDoctor Payments Data

William Zuke, MD

Adult Reconstructive Orthopaedic Surgery · Kalamazoo, MINPI 1972093250

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (30.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 63.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $6,011 and has fallen 84.3% since, to $944 in 2025.

$11,424in general payments, 2019–2025

Across 59 payments — averaging $193.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$7K
  • Stryker$3K
  • FX Shoulder Solutions, Inc$284
  • Johnson & Johnson$204
  • Zimmer Biomet$198
  • Illuminoss Medical, Inc.$146
  • plus $351 from 4 others

What the payments were for

  • Grants$2,50022%
  • Travel & lodging$2,69724%
  • Food & beverage$3,45330%
  • Education$2,77524%

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,424 in reported general payments places this provider in the 55th percentile of 35 adult reconstructive orthopaedic surgery providers in Michigan.

See all adult reconstructive orthopaedic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$36,288
Medicare patients
137
Services billed
261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl126$754
Tramadol Hcl129$480
Pregabalin11$66
Meloxicam22$48

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Kalamazoo

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →